v3.25.3
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2025
Dec. 31, 2024
Current assets:    
Cash and cash equivalents $ 30,815 $ 30,321
Accounts receivable 2,916 3,563
Contract assets and unbilled receivables (Note 11) 1,364 2,209
Prepaids and other current assets 815 515
Short-term investments 0 2
Total current assets 35,910 36,610
Property and equipment, net 212 252
Total assets 36,122 36,862
Current liabilities:    
Accounts payable 2,395 3,148
Accrued expenses and other liabilities 5,367 8,147
Warrant liabilities 21,325 0
Total current liabilities 29,087 11,295
Long-term funding agreement, related party 1,068 0
Total liabilities 30,155 11,295
Commitments and contingencies (Note 4 and Note 10)
Series A preferred stock, par value $0.0001; 14,146 shares were designated as of September 30, 2025 and December 31, 2024; zero and 14,145.374 shares issued and outstanding at September 30, 2025 and December 31, 2024, respectively. 0 18,843
Stockholders' equity:    
Preferred stock, par value $0.0001; 9,985,854 shares authorized as of September 30, 2025 and December 31, 2024; no shares issued and outstanding at September 30, 2025 and December 31, 2024. 0 0
Common stock, par value $0.0001; 125,000,000 shares authorized as of September 30, 2025 and December 31, 2024; 64,544,096 and 31,574,657 shares issued and outstanding at September 30, 2025 and December 31, 2024, respectively. 6 3
Additional paid-in capital 178,027 145,719
Accumulated deficit (172,066) (138,998)
Total stockholders' equity 5,967 6,724
Total liabilities, Series A preferred stock and stockholders' equity $ 36,122 $ 36,862

Source